Notably, Prog significantly counteracted the CDK1-induced upregulation of these enzymes, suggesting a complex interplay where the combination of Abi and Prog disrupts GBM malignancy by targeting CDK1-mediated metabolic pathways. This evidence concerns the gene CDK1 and glioblastoma.